MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Environmental Factors are Associated with Disease Severity of LRRK2 Related Parkinson’s Disease and Idiopathic Parkinson’s Disease: a Longitudinal Study

    T. Lüth, A. Caliebe, C. Gabbert, S. Koch, B-H. Laabs, IR. König, C. Klein, J. Trinh (Lübeck, Germany)

    Objective: To longitudinally analyze the impact of the environment on PD symptom severity in LRRK2 p.Gly2019Ser (LRRK2-PD) and iPD. Background: Smoking, black tea consumption and…
  • 2024 International Congress

    Profile of patients affected by movement disorders in subspecialized outpatient clinics of a tertiary hospital in Southern Brazil

    D. Teixeira-Dos-Santos, G. Magalhães Pereira, T. de Carvalho, P. Ribeiro Rigo, J. Käfer Pasin, I. Fonseca Benati, E. Drews Amorim, M. Testa-da-Silva, T. Lampert Monte, BS. de Oliveira, R. Machado Castilhos, AF. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: To delineate the epidemiological and clinical characteristics of movement disorders (MD) in patients attending subspecialty clinics at a tertiary hospital in Southern Brazil. Background:…
  • 2024 International Congress

    Cohort effects on risk scores and risk markers for Parkinson’s disease – comparison of an online-recruited versus population-based cohort

    K. Marini, C. Theyer, C. Horlings, H. Stockner, K. Schwarzová, I. Egner, A. Djamshidian-Tehrani, G. Rungger, P. Willeit, J. Willeit, S. Kiechl, M. Martì, A. Garrido, E. Tolosa, B. Mollenhauer, C. Trenkwalder, S. Schade, R. Krüger, V. Satagopam, K. Rege, S. Ghosh, T. Marques, D. Mcintyre, K. Seppi, W. Poewe, P. Mahlknecht (Innsbruck, Austria)

    Objective: To compare the distribution of Parkinson’s disease (PD) risk markers and comprehensive risk scores in an online-cohort recruited with open invitations through a media…
  • 2024 International Congress

    Split-belt Treadmill Training to Rehabilitate Freezing of Gait and Balance in Parkinson’s Disease

    S. Sasikumar, A. Fasano, G. Sorrento (Toronto, Canada)

    Objective: Can repeated exposure to a split-belt treadmill (SBTM) encourage motor learning to improve freezing of gait (FOG) and reduce the number of falls in…
  • 2024 International Congress

    An Analysis of Baseline Measures from a Diverse Parkinson’s Disease Interdisciplinary Clinic

    V. Armengol, M. Feldman, M. Sarno, S. Marmol, A. Alfonso, G. Dumenigo, M. Garcia-Casals, S. Munzesheimer, A. Otto, TW. Siu, D. Yacinthe, D. Shpiner (Miami, USA)

    Objective: To analyze differences in baseline characteristics of patients at a new diverse, academic Parkinson’s Disease (PD) interdisciplinary clinic (IDC). Background: The University of Miami…
  • 2024 International Congress

    Cross-sectional study: what is the sleep quality, daytime sleepiness and quality of life like of people with parkinson’s disease at different stages of the disease?

    G. Leveck, L. Paladini, T. Christinelli, V. Israel (CURITIBA, Brazil)

    Objective: To verify sleep quality, daytime sleepiness and quality of life in the different stages of Parkinson's disease (PD). Background: The cholinergic, noradrenergic and serotonergic…
  • 2024 International Congress

    Cohort study and Review on Physiotherapy in the Rehabilitation and Pro-longed Bed Rest of Atypical Parkinsonism’s Syndrome Patients

    A. Mimpriss, J. Donnelly, L. Massey, B. Ghosh (Plymouth, United Kingdom)

    Objective: To present a cohort report on the physical decline and impact on activities of daily life (ADL) of prolonged bedrest for Atypical Parkinsonism's syndrome…
  • 2024 International Congress

    Prevalence of non-motor symptoms and their impact in quality of life in PD: a Mexican Registry, 2011-2019 (the ReMePark-2 study).

    A. Cervantes Arriaga, AJ. Hernandez Medrano, A. Dominguez Garcia, DP. Romero Terán, MF. Medina Perez, M. Rodriguez Violante, A. Abundes Corona, R. Solis Vivanco, AL. Guerra-Anzaldo, G. Rivera-Monroy, CF. álvarez-Hernández, RJ. Baños-Betancourt, WF. Moguel Cardín ()

    Objective: To determine the prevalence of non-motor symptoms (NMS) and their impact on quality of life (QoL) in Mexican individuals with Parkinson's disease (PD), aiming…
  • 2024 International Congress

    Transforming Parkinson’s Care in Africa: Establishing the First Ever Support Group for People With Parkinson’s Disease and Their Caregivers in Tanzania.

    M. Shayo, K. Haukila, T. Park, R. Walker, N. Fothergill-Misbah (Moshi, United Republic of Tanzania)

    Objective: To establish a support group for people with Parkinson's disease (PwP) and caregivers in Tanzania as part of the Transforming Parkinson’s Care in Africa…
  • 2024 International Congress

    WATCH-PD Qualitative Study: A Mental Model of Coping with Disease Progression

    A. Lerner, J. Mammen, R. Al-Rubayie, M. Kostrzebski, J. Adams (Rochester, USA)

    Objective: To qualitatively evaluate how individuals’ adjust to and cope with symptoms of Parkinson’s disease (PD). Background: The WATCH-PD qualitative study is evaluating meaningful symptoms…
  • « Previous Page
  • 1
  • …
  • 76
  • 77
  • 78
  • 79
  • 80
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley